microRNA sequencing for biomarker detection in the diagnosis, classification and prognosis of Diffuse Large B Cell Lymphoma

microRNA sequencing for biomarker detection in the diagnosis, classification and prognosis of Diffuse Large B Cell Lymphoma

Abstract Despite being considered a single disease, Diffuse Large B Cell Lymphoma (DLBCL) presents with variable backgrounds, which results in heterogeneous outcomes among patients, with 40% of them still having primary refractory disease or relapse. Thus, novel biomarkers are needed. In addition, m...

Full description

Bibliographic Details
Main Authors: Ane Larrabeiti-Etxebarria, Nerea Bilbao-Aldaiturriaga, Javier Arzuaga-Mendez, Maialen Martin-Arruti, Luca Cozzuto, Ayman Gaafar, Irune Ruiz-Diaz, Isabel Guerra, Idoia Martin-Guerrero, Elixabet Lopez-Lopez, Angela Gutierrez-Camino
Format: Article
Language:English
Published: Nature Portfolio 2023-07-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-39271-7

Internet

https://doi.org/10.1038/s41598-023-39271-7

Similar Items